[Prevention in schizophrenia.]

[Prevention in schizophrenia.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Prevention in schizophrenia.] Abstract Text:

Functional consequences of schizophrenia are important. According to this, prevention has been developed using various approaches. The strategy based on the neuro-developmental hypothesis of the illness is not useful at the time. Identification of ultra high risk groups is an interesting way to develop possibilities of intervention which goal is to reduce the possibility of transition to psychosis in those samples. But the lack of specificity of the definition of those groups, make this strategy difficult to use in general population. Increasing the permeability of the different filters along the pathway to mental health care can be more promising in general population. By now, prevention strategies have to be improved in the filed of schizophrenia, and make the proof of ther interest beyond the research perspectives. La schizophrénie est une pathologie dont les conséquences fonctionnelles sont majeures. Plusieurs approches préventives ont été développées. Les approches précoces basées sur l'hypothèse neuro-développementale restent peu opérationnelles. C'est l'identification de groupes à haut risque qui permet dans des populations spécifiques de développer des prises en charge visant à diminuer le risque de transition psychotique. Toutefois le manque de spécificité pour définir ces groupes rend cette stratégie peu intéressante en population générale. La diminution des filtres au cours du parcours de soin des patients pourrait être une approche plus prometteuse en population générale. Ces différentes stratégies doivent être développées mais également faire la preuve de leur intérêt pratique au-delà des perspectives de recherche.

[Prevention in schizophrenia.] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 2008 May-Jun

[Prevention in schizophrenia.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Thérapie

VOLUME: 63

Page Numbers: 251-5

Journal Abbreviation: Therapie

ISSN: 0040-5957

DAY: 23

MONTH: 08

YEAR: 2008

[Prevention in schizophrenia.] Information

Number of References:

LANGUAGE: fre

NlmUniqueID: 420544

[Prevention in schizophrenia.] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Prevention in schizophrenia.] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Prevention in schizophrenia.]

AFFILIATION: CMP B CHU, Clermont Ferrand, France.

Country: France

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Therapie

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prevention in schizophrenia Related Publications

• 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.
• Cyclooxygenase-2 (Cox-2) and blast cells of patients with acute leukemia.
• Resistance to Bacitracin in Bacillus subtilis: unexpected requirement of the BceAB ABC transporter in the control of expression of its own structural genes.
• The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
• The 3'IgH regulatory region is active at immature stages of B-cell development.
• [Comparative histochemical study of mucopolysaccharides in the ampullary sense organs of weakly electric fish: Gnathonemus petersii (Mormyridae), Gymnotus carapo (Gymnotidae) and Gymnarchus niloticus (Gymnarchidae)]
• [Histochemical study of mucopolysaccharides of mormyromast (type II of Cordier) in mormyrides, Gnathonemus petersii]
• [Prevention in schizophrenia.]